Aditxt, Inc. (ADTX)
NASDAQ: ADTX · Real-Time Price · USD
1.630
-0.160 (-8.94%)
At close: May 13, 2025, 4:00 PM
1.580
-0.050 (-3.07%)
Pre-market: May 14, 2025, 7:17 AM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021
Period Ending
Dec '23 Dec '22 Dec '21
Immune Reprogramming Technologies
645.18K
Log In
Log In
Immune Reprogramming Technologies Growth
-30.90%
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021
Period Ending
Dec '23 Dec '22 Dec '21
United States
645.18K
Log In
Log In
United States Growth
-30.90%
Log In
Log In